β-arrestin1 at the cross-road of endothelin-1 signaling in cancer

[1]  V. Caprara,et al.  Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer. , 2016, Life sciences.

[2]  V. Caprara,et al.  Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis. , 2016, Life sciences.

[3]  G. Ferrandina,et al.  Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma , 2016, Oncogene.

[4]  E. Turley,et al.  KISS1R signaling promotes invadopodia formation in human breast cancer cell via β-arrestin2/ERK. , 2016, Cellular signalling.

[5]  R. Singh,et al.  β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation , 2016, Molecular Cancer Research.

[6]  V. Caprara,et al.  Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression , 2016, Oncotarget.

[7]  S. Shenoy,et al.  Ubiquitin‐Related Roles of β‐Arrestins in Endocytic Trafficking and Signal Transduction , 2016, Journal of cellular physiology.

[8]  L. Rosanò,et al.  Endothelin therapeutics in cancer: Where are we? , 2016, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  K. Jalink,et al.  Rapid Remodeling of Invadosomes by Gi-coupled Receptors , 2016, The Journal of Biological Chemistry.

[10]  G. Blandino,et al.  miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma , 2015, Oncotarget.

[11]  K. Ohshima,et al.  Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas , 2016, Journal of Neuro-Oncology.

[12]  W. Ji,et al.  β‐Arrestin2 Contributes to Cell Viability and Proliferation via the Down‐Regulation of FOXO1 in Castration‐Resistant Prostate Cancer , 2015, Journal of cellular physiology.

[13]  K. Aldape,et al.  Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice , 2015, Clinical Cancer Research.

[14]  Guihua Chen,et al.  β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling , 2015, Nature Communications.

[15]  X. Qu,et al.  β-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor. , 2015, International journal of clinical and experimental pathology.

[16]  Tiehong Zhang,et al.  Co-expression of β-arrestin1 and NF-кB is associated with cancer progression and poor prognosis in lung adenocarcinoma , 2015, Tumor Biology.

[17]  G. Bepler,et al.  β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition. , 2015, Cancer research.

[18]  Weiwei Li,et al.  β-arrestin 2 is associated with multidrug resistance in breast cancer cells through regulating MDR1 gene expression. , 2015, International journal of clinical and experimental pathology.

[19]  Zhidai Liu,et al.  β-Arrestin1 promotes the self-renewal of the leukemia-initiating cell-enriched subpopulation in B-lineage acute lymphoblastic leukemia related to DNMT1 activity. , 2015, Cancer letters.

[20]  Stephen P. Cavnar,et al.  CXCL12-γ in Primary Tumors Drives Breast Cancer Metastasis , 2014, Oncogene.

[21]  Sung-Chou Li,et al.  Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer. , 2015, Oncology reports.

[22]  F. Spinella,et al.  Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. , 2014, Cancer research.

[23]  I. Fidler,et al.  Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells. , 2014, Neuro-oncology.

[24]  Shuang Huang,et al.  Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. , 2014, Cellular signalling.

[25]  F. Spinella,et al.  β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. , 2014, Life sciences.

[26]  Hongtu Zheng,et al.  Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer through ERK and β-arrestin pathways. , 2014, International journal of oncology.

[27]  Xuhui Zhou,et al.  Knockdown of CXCR7 inhibits proliferation and invasion of osteosarcoma cells through inhibition of the PI3K/Akt and β-arrestin pathways. , 2014, Oncology reports.

[28]  M. Jordá,et al.  The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation , 2014, Molecular Cancer.

[29]  D. Coppola,et al.  Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC , 2014, Oncotarget.

[30]  Y. Daaka,et al.  Arrestin2 modulates androgen receptor activation , 2014, Oncogene.

[31]  Peng-hui Zhang,et al.  β-Arrestin1 promotes the progression of chronic myeloid leukaemia by regulating BCR/ABL H4 acetylation , 2014, British Journal of Cancer.

[32]  D. Rossi,et al.  Endothelin-1 Promotes Survival and Chemoresistance in Chronic Lymphocytic Leukemia B Cells through ETA Receptor , 2014, PloS one.

[33]  I. Mills,et al.  Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer , 2014, The EMBO journal.

[34]  B. Sullenger,et al.  Targeted Disruption of β-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth , 2014, PloS one.

[35]  Ian C. Clift,et al.  β-Arrestin1 and Distinct CXCR4 Structures Are Required for Stromal Derived Factor-1 to Downregulate CXCR4 Cell-Surface Levels in Neuroblastoma , 2014, Molecular Pharmacology.

[36]  F. Spinella,et al.  The interplay between hypoxia, endothelial and melanoma cells regulates vascularization and cell motility through endothelin-1 and vascular endothelial growth factor. , 2014, Carcinogenesis.

[37]  M. Wu,et al.  Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells , 2014, Oncogene.

[38]  S. Muthuswamy,et al.  G-protein–coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion , 2014, Proceedings of the National Academy of Sciences.

[39]  S. Chellappan,et al.  Nicotine-Mediated Cell Proliferation and Tumor Progression in Smoking-Related Cancers , 2014, Molecular Cancer Research.

[40]  F. Spinella,et al.  β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling , 2013, Oncogene.

[41]  T. Wang,et al.  Progastrin stimulates colonic cell proliferation via CCK2R- and β-arrestin-dependent suppression of BMP2. , 2013, Gastroenterology.

[42]  M. Hung,et al.  Mesenchymal stem cells promote growth and angiogenesis of tumors in mice , 2013, Oncogene.

[43]  F. Spinella,et al.  Endothelin 1 in cancer: biological implications and therapeutic opportunities , 2013, Nature Reviews Cancer.

[44]  M. Topham,et al.  Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice. , 2013, Cancer research.

[45]  G. Metodieva,et al.  Pseudopodial and β-arrestin-interacting proteomes from migrating breast cancer cells upon PAR2 activation. , 2013, Journal of proteomics.

[46]  B. Cain,et al.  An emerging role for microRNA in the regulation of endothelin-1 , 2013, Front. Physio..

[47]  Sandeep Singh,et al.  βArrestin-1 and Mcl-1 Modulate Self-Renewal Growth of Cancer Stem-Like Side-Population Cells in Non-Small Cell Lung Cancer , 2013, PloS one.

[48]  G. M. Di Guglielmo,et al.  β-Arrestin2 Regulates Lysophosphatidic Acid-Induced Human Breast Tumor Cell Migration and Invasion via Rap1 and IQGAP1 , 2013, PloS one.

[49]  R. Buckanovich,et al.  Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cells , 2013, Cancer biology & therapy.

[50]  F. Spinella,et al.  Endothelin-1 induces the transactivation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells , 2013, Journal of Molecular Medicine.

[51]  L. Girnita,et al.  β-Arrestin–biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor–targeting antibodies in Ewing’s sarcoma , 2012, Proceedings of the National Academy of Sciences.

[52]  A. Davenport,et al.  Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways. , 2012, Life sciences.

[53]  Pengyuan Yang,et al.  MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. , 2012, Life sciences.

[54]  R. Lefkowitz,et al.  β-Arrestin2 mediates the initiation and progression of myeloid leukemia , 2012, Proceedings of the National Academy of Sciences.

[55]  D. Abraham,et al.  Endothelin‐1 stimulates colon cancer adjacent fibroblasts , 2012, International journal of cancer.

[56]  J. Desvignes,et al.  Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[57]  S. Chellappan,et al.  Nicotine-mediated induction of E-selectin in aortic endothelial cells requires Src kinase and E2F1 transcriptional activity. , 2012, Biochemical and biophysical research communications.

[58]  I. Fidler,et al.  Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist. , 2012, Translational oncology.

[59]  R. Ye,et al.  Identification of a Nuclear Localization Sequence in β-Arrestin-1 and Its Functional Implications* , 2012, The Journal of Biological Chemistry.

[60]  M. Dewhirst,et al.  β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression , 2011, Oncogene.

[61]  Jia-jun Du,et al.  Expression of β-arrestin 1 in gastric cardiac adenocarcinoma and its relation with progression. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[62]  A. Lowy,et al.  Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells , 2012, Journal of Translational Medicine.

[63]  Peng-hui Zhang,et al.  β-arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression. , 2011, Oncology reports.

[64]  Jungah Min,et al.  β-Arrestin-Dependent Actin Reorganization: Bringing the Right Players Together at the Leading Edge , 2011, Molecular Pharmacology.

[65]  Kunhong Xiao,et al.  A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1 , 2011, Nature.

[66]  R. Lefkowitz,et al.  Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. , 2011, Trends in biochemical sciences.

[67]  G. M. Di Guglielmo,et al.  GPR54 (KISS1R) Transactivates EGFR to Promote Breast Cancer Cell Invasiveness , 2011, PloS one.

[68]  K. Jirström,et al.  Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer. , 2011, The Journal of molecular diagnostics : JMD.

[69]  Peng-hui Zhang,et al.  Elevated β-arrestin1 expression correlated with risk stratification in acute lymphoblastic leukemia , 2011, International journal of hematology.

[70]  D. Coppola,et al.  ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors. , 2011, Journal of the National Cancer Institute.

[71]  X. Deupí,et al.  Faculty Opinions recommendation of Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). , 2011 .

[72]  I. Fidler,et al.  Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer. , 2011, Neoplasia.

[73]  F. Spinella,et al.  Acquisition of Chemoresistance and EMT Phenotype Is Linked with Activation of the Endothelin A Receptor Pathway in Ovarian Carcinoma Cells , 2011, Clinical Cancer Research.

[74]  D. Theodorescu,et al.  Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer. , 2011, The Journal of clinical investigation.

[75]  S. Gygi,et al.  Global phosphorylation analysis of β-arrestin–mediated signaling downstream of a seven transmembrane receptor (7TMR) , 2010, Proceedings of the National Academy of Sciences.

[76]  F. Spinella,et al.  β-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinaseThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research. , 2010 .

[77]  Y. Daaka,et al.  Prostaglandin E2 Promotes Lung Cancer Cell Migration via EP4-βArrestin1-c-Src Signalsome , 2010, Molecular Cancer Research.

[78]  F. Spinella,et al.  Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase. , 2010, Canadian journal of physiology and pharmacology.

[79]  G. Mills,et al.  β-Arrestin/Ral Signaling Regulates Lysophosphatidic Acid–Mediated Migration and Invasion of Human Breast Tumor Cells , 2009, Molecular Cancer Research.

[80]  J. Benovic,et al.  Identification of βArrestin2 as a corepressor of androgen receptor signaling in prostate cancer , 2009, Proceedings of the National Academy of Sciences.

[81]  F. Casanueva,et al.  Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. , 2009, Endocrine-related cancer.

[82]  Annamaria Biroccio,et al.  β-Arrestin links endothelin A receptor to β-catenin signaling to induce ovarian cancer cell invasion and metastasis , 2009, Proceedings of the National Academy of Sciences.

[83]  X. Sun,et al.  beta-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways. , 2009, Neoplasma.

[84]  P. Gimotty,et al.  Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy , 2008, Nature Medicine.

[85]  S. Chellappan,et al.  Nicotine-Mediated Cell Proliferation and Angiogenesis: New Twists to an Old Story , 2006, Cell cycle.

[86]  S. Chellappan,et al.  Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. , 2006, The Journal of clinical investigation.

[87]  Qiong Shi,et al.  Role of β-arrestin 1 in the metastatic progression of colorectal cancer , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Lan Ma,et al.  A nuclear function of beta-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription (vol 123, pg 833, 2005) , 2006 .

[89]  Qiong Shi,et al.  Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[90]  Min Zhang,et al.  A Nuclear Function of β-Arrestin1 in GPCR Signaling: Regulation of Histone Acetylation and Gene Transcription , 2005, Cell.

[91]  R. Lefkowitz,et al.  Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2* , 2004, Journal of Biological Chemistry.

[92]  J. Nelson,et al.  The endothelin axis: emerging role in cancer , 2003, Nature Reviews Cancer.

[93]  Yue Sun,et al.  β-Arrestin2 Is Critically Involved in CXCR4-mediated Chemotaxis, and This Is Mediated by Its Enhancement of p38 MAPK Activation* , 2002, The Journal of Biological Chemistry.